학술논문

Survival outcomes with 12 weeks of adjuvant or neoadjuvant trastuzumab in breast cancer
Document Type
Article
Source
In: Indian Journal of Cancer. (Indian Journal of Cancer, July 2022, 59(3):387-393)
Subject
Language
English
ISSN
19984774
0019509X